| Pharmacokinetics And Relative Bioavailability Of Bococizumab (PF-04950615; RN316) When Administered To The Abdomen, Thigh Or Upper Arm (NCT02043301) | Pfizer | 2014-04-01 |
| Food Matrix and Genetic Variability as Determinants of Bioavailability and Biological Effects of Beta-cryptoxanthin and Phytosterols (NCT02065024) | Puerta de Hierro University Hospital | 2014-03-01 |
| Effect of an Atlantic Diet on Anthropometric Indices and Serum Lipid Profile (NCT02391701) | Hospital Clinico Universitario de Santiago | 2014-03-01 |
| Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy (NCT02072161) | Esperion Therapeutics, Inc. | 2014-03-01 |
| Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN) (NCT02107898) | Sanofi | 2014-03-01 |
| Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects (NCT02055976) | Pfizer | 2014-03-01 |
| Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia (NCT02100839) | LipimetiX Development, LLC | 2014-03-01 |
| Open Label Study of Long Term Safety Evaluation of Alirocumab (NCT01954394) | Sanofi | 2013-12-17 |
| Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II) (NCT02023879) | Sanofi | 2013-12-16 |
| Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol (NCT01959971) | Sanofi | 2013-12-01 |
| A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia. (NCT01982461) | Pin Siang Medical Biotechnology Co., Ltd. | 2013-11-01 |
| Effect of L. Reuteri NCIMB 30242 on Plasma Bile Acid Profile (NCT02216825) | Micropharma Limited | 2013-11-01 |
| Combined Effect of LIMICOL and Physical Activity on LDL Cholesterol and Muscle Function. (NCT05750602) | Lescuyer Laboratory | 2013-11-01 |
| The Effect of Psyllium Fibre on LDL-C, Non-HDL-C, and Apolioprotein-B: A Systematic Review and Meta-analysis (NCT03346733) | Unity Health Toronto | 2013-10-08 |
| Study of Awareness and Detection of Familial Hypercholesterolemia (NCT01960244) | The Familial Hypercholesterolemia Foundation | 2013-10-01 |
| Effect of Statin Treatment on Urinary AQP2 (uAQP2/01) (NCT02523001) | University of Bari | 2013-10-01 |
| Actual Use Trial of Atorvastatin Calcium 10 mg (NCT01964326) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2013-10-01 |
| Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients (NCT01941836) | Esperion Therapeutics, Inc. | 2013-09-01 |
| The Effect of Synching Prescription Refills on Adherence (NCT01934608) | University of Pennsylvania | 2013-09-01 |
| Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1) (NCT01926782) | Regeneron Pharmaceuticals | 2013-09-01 |
| Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia (NCT01912560) | Catabasis Pharmaceuticals | 2013-07-01 |
| Genetically Guided Statin Therapy (NCT01894230) | Duke University | 2013-07-01 |
| A Study of LY3015014 in Participants With High Cholesterol (NCT01890967) | Eli Lilly and Company | 2013-06-01 |
| Safety Study of Bile Acid to Treat Hypercholesteremia (NCT01931241) | AtheroNova Inc. | 2013-06-01 |
| A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022) (NCT01860729) | Merck Sharp & Dohme LLC | 2013-05-13 |
| Probiotic BIO-25 as a Supplement to Statins for the Treatment of Hypercholesterolemia (NCT01849185) | Meir Medical Center | 2013-05-01 |
| GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound (NCT01813422) | Amgen | 2013-04-18 |
| Comparison of the Efficacy of Plant Sterol-Enriched Soymilk Versus Plain Soymilk in Volunteers With High LDL-Cholesterol (NCT02459314) | Chiang Mai University | 2013-04-01 |
| Effects of Dietary Antioxidants to Prevent Cardiovascular Disease (NCT02409537) | Aeromedical Center, Thessaloniki | 2013-03-01 |
| Serum Cholesterol Reduction Efficacy of Biscuit With Plant Stanol Ester (NCT02331043) | Raisio Group | 2013-03-01 |
| Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in Japan (NCT01812707) | Sanofi | 2013-03-01 |
| Effect of Plant Sterol Enriched Milk on Plasma Lipid Levels of Humans Breast-fed During Infancy (NCT01825668) | University of Manitoba | 2013-03-01 |
| Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia (NCT01420549) | Ache Laboratorios Farmaceuticos S.A. | 2013-03-01 |
| Low Fat Vegan or American Heart Association Diets & Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol (NCT01817491) | The Cleveland Clinic | 2013-03-01 |
| Effects of The Effects of Dietary Oils on Fasting Lipoprotein Lipids (NCT01925716) | ACH Food Companies, Inc. | 2013-03-01 |
| Effect of Dietary Intervention on LDL-C and Lipoprotein Subclasses Distribution in Patients With Hypercholesterolemia (NCT04148976) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2013-02-28 |
| Medication Adherence With Polyglot Meducation (NCT01744392) | Durham VA Medical Center | 2013-02-01 |
| The Effect of Plant Sterols on Vascular Function (NCT01803178) | Unilever R&D | 2013-02-01 |
| Pharmacokinetic of Alirocumab SAR236553 (REGN727) Administered Subcutaneously at 3 Different Injection Sites in Healthy Subjects (NCT01785329) | Sanofi | 2013-02-01 |
| Effectiveness of a Combined Strategy to Improve Therapeutic Compliance and Degree of Control Among Patients With Hypercholesterolaemia (NCT02314663) | Gerencia de Atención Primaria, Albacete | 2013-01-01 |
| U of A/ U of M Beans and Peas Health Claim Project (NCT01661543) | University of Alberta | 2013-01-01 |
| Cholesterol Medication Packaging Study (NCT01744977) | Durham VA Medical Center | 2012-12-01 |
| A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia (NCT01779453) | Esperion Therapeutics, Inc. | 2012-12-01 |
| Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II) (NCT01730053) | Regeneron Pharmaceuticals | 2012-11-30 |
| A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy (MK-0859-021) (NCT01717300) | Merck Sharp & Dohme LLC | 2012-11-06 |
| Effect of Atorvastatin on Bone-vascular Axis (NCT02342015) | University of Padova | 2012-11-01 |
| A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia (NCT01651273) | Bristol-Myers Squibb | 2012-11-01 |
| Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects (NCT01723735) | Sanofi | 2012-11-01 |
| A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin Intolerance (NCT01751984) | Esperion Therapeutics, Inc. | 2012-10-04 |
| Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS (NCT01702987) | Beth Israel Deaconess Medical Center | 2012-10-01 |
| Observational Study to Understand Patients' and Physicians' Attitudes to Statins in TurkeY (NCT01625884) | AstraZeneca | 2012-10-01 |
| Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I) (NCT01730040) | Regeneron Pharmaceuticals | 2012-10-01 |
| Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE) (NCT01709513) | Regeneron Pharmaceuticals | 2012-09-30 |
| Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients (NCT01678521) | Universita di Verona | 2012-09-01 |
| Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen (NCT01705873) | Helios Salud | 2012-09-01 |
| Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects (NCT01670734) | Sanofi | 2012-09-01 |
| One-Day Acceptance and Commitment Training Intervention in Primary Care Patients (NCT01879800) | Lilian N. Dindo | 2012-08-01 |
| Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule (NCT01630668) | Micropharma Limited | 2012-08-01 |
| A Study of LY3015014 in Healthy Participants With High Cholesterol (NCT01671085) | Eli Lilly and Company | 2012-08-01 |
| Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II) (NCT01644188) | Sanofi | 2012-08-01 |
| A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541) (NCT01611883) | Organon and Co | 2012-07-02 |
| Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin (NCT01592240) | Pfizer | 2012-07-01 |
| Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy (NCT01623115) | Sanofi | 2012-07-01 |
| Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With Hypercholesterolemia (NCT01644474) | Sanofi | 2012-07-01 |
| A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects (NCT01720537) | Pfizer | 2012-07-01 |
| Randomized Trial of the Impact of Body Scanning and Intensive Behavioral Intervention on Behavioral Change and Health Outcomes (NCT03392350) | Reengineering Healthcare Inc. | 2012-06-15 |
| Intervention With Lupin Protein-enriched Foods in Hypercholesterolemic Subjects (NCT01598649) | University of Jena | 2012-06-01 |
| A Human Trial to Assess the Low Density Lipoprotein Cholesterol (LDL-C) Lowering Effect of Soy (NCT01547585) | Guelph Food Research Centre | 2012-05-01 |
| The Effect of CBT- Based Weight Loss Program on Obesity (NCT01606904) | University of Oulu | 2012-05-01 |
| Efficacy and Safety of Pitavastatin in a Real-world Setting (NCT04402112) | JW Pharmaceutical | 2012-04-02 |
| Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement (NCT01743313) | Coxa, Hospital for Joint Replacement | 2012-04-01 |
| Effects of Purple Vegetables on Cardiovascular Disease (CVD) Risk Factors (NCT01564498) | University of Guelph | 2012-04-01 |
| Plant Stanols and Gene Expression Profile (NCT01574417) | Maastricht University Medical Center | 2012-03-01 |
| Gut Flora and Lipid Metabolism (NCT01566266) | Maastricht University Medical Center | 2012-03-01 |
| Lentils as a Functional Food to Improve Glucose and Decrease Cardiovascular Risk (NCT01562171) | University of Manitoba | 2012-03-01 |
| Genetic Influence on Statin Pharmacodynamics (NCT01569854) | Ohio State University | 2012-03-01 |
| Open-Label Extension of Study R727-CL-1003 (NCT01266876) to Evaluate the Long-Term Safety and Efficacy of Alirocumab (REGN727) in Participants With Heterozygous Familial Hypercholesterolemia (HeFH) (NCT01576484) | Regeneron Pharmaceuticals | 2012-02-28 |
| Supplementation of Alpha-linolenic Acid (ALA)-Rich Oil in Humans (NCT01317290) | University of Jena | 2012-02-01 |
| The Rosuvastatin In TrAnsplant Recipients Study (NCT01524601) | University of Oslo School of Pharmacy | 2012-02-01 |
| Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study (NCT01516879) | Amgen | 2012-01-05 |
| A Comparison of the Effects on Cardiovascular Risk Factors of Korean and American Dietary Profiles (NCT01617525) | USDA Beltsville Human Nutrition Research Center | 2012-01-01 |
| Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term) (NCT01507831) | Sanofi | 2012-01-01 |
| A Study Comparing CoQ10 Levels While Taking 3 Different Statins (NCT01660191) | University of Kansas Medical Center | 2011-12-01 |
| A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol (NCT01475825) | Kastle Therapeutics, LLC | 2011-12-01 |
| Single Oral Dose of BeneFlax to Healthy Young and Older Adults (NCT01531569) | University of Saskatchewan | 2011-12-01 |
| Vascular and Metabolic Effects of Vytorin vs Simvastatin (NCT01666067) | Gachon University Gil Medical Center | 2011-11-01 |
| Influence of OATP1B1 and BRCP Genotype on Rosuvastatin PK, PD and Lipidomics in Hyperlipidemic Patients (NCT01466608) | Seoul National University Hospital | 2011-11-01 |
| Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia (NCT01710007) | Orient Pharma Co., Ltd. | 2011-11-01 |
| Open Label Study of Long Term Evaluation Against LDL-C Trial (NCT01439880) | Amgen | 2011-10-07 |
| A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia (NCT01435382) | Pfizer | 2011-10-01 |
| Vascular and Metabolic Effects of Rosuvastatin (NCT01660919) | Gachon University Gil Medical Center | 2011-10-01 |
| Effect of Niacin in the Lipoprotein (a) Concentration (NCT01321034) | Instituto Aragones de Ciencias de la Salud | 2011-10-01 |
| A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1) (NCT01370603) | Organon and Co | 2011-09-01 |
| A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1) (NCT01370590) | Organon and Co | 2011-09-01 |
| Cholesterol-lowering Effects of Plant Stanol Ester (NCT02316808) | Raisio Group | 2011-08-01 |
| Investigation of the Effect of Dietary Nitrate Treatment on Endothelial Function and Platelet Reactivity in Hypercholesterolemics. (NCT01493752) | Queen Mary University of London | 2011-08-01 |
| A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1) (NCT01333436) | Organon and Co | 2011-07-20 |
| Injection Site Tolerability, Safety, Pharmacokinetics, Pharmacodynamics in Different Single-Dose Treatments of Alirocumab SAR236553 (REGN727) in Healthy Subjects (NCT01443650) | Sanofi | 2011-07-01 |
| Vascular and Metabolic Effects of Vytorin (NCT01660945) | Gachon University Gil Medical Center | 2011-07-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins (NCT01859455) | Novartis Pharmaceuticals | 2011-07-01 |